Exclusive: Carlyle explores sale or IPO of Ortho-Clinical Diagnostics - sources

(Reuters) - Private equity firm Carlyle Group LP is exploring a sale or initial public offering of Ortho-Clinical Diagnostics Inc, a U.S. diagnostics company that could be valued at more than $7 billion, including debt, people familiar with the matter said.

Exclusive: Carlyle explores sale or IPO of Ortho-Clinical Diagnostics - sources
Read More


Bagikan Berita Ini